Structural basis for partial agonism in 5-HT_3A receptors

Area of Science:

• Neuroscience
• Pharmacology
• Structural Biology

Background:

• Serotonin 3 receptors (5-HT3R) hyperactivity is implicated in irritable bowel syndrome and chemotherapy-induced nausea and vomiting.
• Current treatments (setrons) are effective but have adverse side effects, particularly for irritable bowel syndrome.
• Partial agonists are a promising alternative, but their structural mechanisms are poorly understood.

Purpose of the Study:

• To elucidate the structural mechanisms underlying the function of 5-HT3 receptor partial agonists.
• To understand the molecular basis for differential pharmacology between agonists and antagonists at the 5-HT3 receptor.

Main Methods:

• High-resolution cryogenic electron microscopy (cryo-EM) was used to determine the structures of the mouse 5-HT3A receptor.
• Structures were obtained in complex with partial agonists SMP-100 and ALB-148471.
• Molecular dynamics (MD) simulations were employed to analyze drug-binding stability and interactions.

Main Results:

• High-resolution structures of the 5-HT3A receptor in complex with partial agonists were determined.
• The structures captured pre-activated and open-like conformational states of the receptor.
• MD simulations provided insights into the stability and dynamics of ligand-receptor interactions.

Conclusions:

• The study reveals the structural mechanisms differentiating partial agonists from full agonists and antagonists at the 5-HT3A receptor.
• This structural understanding provides a basis for designing novel therapeutics with improved efficacy and reduced side effects.
• Findings pave the way for developing better treatments for conditions like irritable bowel syndrome and chemotherapy-induced nausea.